CHINOOK THERAPEUTICS, INC. 3 SEC Filings

Filed On	Filing
12 Apr 2023	Form 3: Azelby Robert, Director No securities owned
16 Feb 2023	Form 3: Oxtoby Andrew, Chief Commercial Officer No securities owned
29 Mar 2022	Form 3: Krishnan Mahesh, Director No securities owned
17 Nov 2020	Form 3: Bjerkholt Eric, Chief Financial Officer Holds 10,000 shares of Common Stock
07 Oct 2020	Form 3: Glicklich Alan, Chief Medical Officer No securities owned
07 Oct 2020	Form 3: King Andrew James, Head of Renal Discovery No securities owned
07 Oct 2020	Form 3: Versant Venture Capital VII, L.p., 10% owner and 2 others Holds 4,733,023 shares of Common Stock
07 Oct 2020	Form 3: Akkaraju Srinivas, Director No securities owned
07 Oct 2020	Form 3: Thomas Dolca, Director No securities owned
07 Oct 2020	Form 3: Griffin Michelle Renee, Director No securities owned
07 Oct 2020	Form 3: Jerel Davis, Director No securities owned
07 Oct 2020	Form 3: Frohlich Tom, Chief Business Officer No securities owned
07 Oct 2020	Form 3: Dobmeier Eric, Director No securities owned
29 Jan 2020	Form 3: Kachioff William G, See Remarks No securities owned
15 Jul 2019	Form 3: Welch James H, See Remarks No securities owned
15 May 2019	Form 3: Nuyten Dimitry Sa, Chief Medical Officer No securities owned
19 Apr 2019	Form 3: Karbe Frank, Director No securities owned
21 Feb 2019	Form 3: Mack David Henry, Director No securities owned
07 Feb 2019	Form 3: Ferber Celeste, SVP, GC and Secretary Holds 2,591 shares of Common Stock
07 Dec 2018	Form 3: Hoth Daniel Floyd Jr, Interim Chief Medical Officer No securities owned

Comments